JOSEPH GULFO was named executive director of the Rothman Institute of Innovation and Entrepreneurship at Fairleigh Dickinson University.
Health Canada approved a new indication for the use of Xtandi (enzalutamide) capsules to treat patients with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.
PURDUE UNIVERSITY Center for Cancer Research was renewed as an NCI-designated basic science cancer center, and was awarded $8 million in funding over the next five years. In its review, the institute rated the center as “outstanding.”
President Barack Obama signed the Medicare Access and Children's Health Insurance Program Reauthorization Act on April 14, permanently repealing the Medicare sustainable growth rate formula.
Immunocore Ltd. and MedImmune, the global biologics research and development arm of AstraZeneca, entered into a second collaboration.
Bayer HealthCare expanded its global clinical development program for the investigational oncology compound copanlisib (BAY 80-6946), which now includes two new phase III studies in indolent non-Hodgkin's lymphomas and one additional phase II study in diffuse large B-cell lymphoma.
ROCHE acquired CAPP Medical, a genomics research company founded by members of Stanford University, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood. CAPP Medical’s novel technology is designed to isolate and quantify small amounts of ctDNA through a blood draw, which can be […]
CHILDREN’S HOSPITAL OF WISCONSIN opened its MACC Fund Center clinic and Northwestern Mutual Day Hospital. “Children’s Hospital of Wisconsin is grateful for its long standing partnership with the MACC Fund, an organization exceptionally dedicated to children with cancer and blood disorders,” said Peggy Troy, CEO of the Children’s Hospital of Wisconsin. “Through the support of […]
DON GABRIEL joined the Global Clinical Development & Operations team of United BioSource Corp., a subsidiary of Express Scripts. Gabriel will direct UBC’s consultative services to pharmaceutical sponsors developing oncology therapies. A bone marrow transplant physician, Gabriel held a long tenure at the University of North Carolina where he served as professor of medicine, associate […]
GERRIT LOS was named vice president of pharmacology at AnaptysBio Inc.
